Cargando…
Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183776/ http://dx.doi.org/10.1038/bcj.2014.68 |
| _version_ | 1782337746952519680 |
|---|---|
| author | Cummins, K D Jane, S M Ninkovic, S Bazargan, A Filshie, R Sutrave, G Hertzberg, M Scott, A Lane, S Yannakou, C K Ritchie, D D'Rozario, J Black, J Bavishi, K Wei, A |
| author_facet | Cummins, K D Jane, S M Ninkovic, S Bazargan, A Filshie, R Sutrave, G Hertzberg, M Scott, A Lane, S Yannakou, C K Ritchie, D D'Rozario, J Black, J Bavishi, K Wei, A |
| author_sort | Cummins, K D |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4183776 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-41837762014-10-03 Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia Cummins, K D Jane, S M Ninkovic, S Bazargan, A Filshie, R Sutrave, G Hertzberg, M Scott, A Lane, S Yannakou, C K Ritchie, D D'Rozario, J Black, J Bavishi, K Wei, A Blood Cancer J Corrigendum Nature Publishing Group 2014-09 2014-09-19 /pmc/articles/PMC4183776/ http://dx.doi.org/10.1038/bcj.2014.68 Text en Copyright © 2014 Macmillan Publishers Limited |
| spellingShingle | Corrigendum Cummins, K D Jane, S M Ninkovic, S Bazargan, A Filshie, R Sutrave, G Hertzberg, M Scott, A Lane, S Yannakou, C K Ritchie, D D'Rozario, J Black, J Bavishi, K Wei, A Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia |
| title | Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia |
| title_full | Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia |
| title_fullStr | Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia |
| title_full_unstemmed | Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia |
| title_short | Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia |
| title_sort | sorafenib priming may augment salvage chemotherapy in relapsed and refractory flt3-itd-positive acute myeloid leukemia |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183776/ http://dx.doi.org/10.1038/bcj.2014.68 |
| work_keys_str_mv | AT cumminskd sorafenibprimingmayaugmentsalvagechemotherapyinrelapsedandrefractoryflt3itdpositiveacutemyeloidleukemia AT janesm sorafenibprimingmayaugmentsalvagechemotherapyinrelapsedandrefractoryflt3itdpositiveacutemyeloidleukemia AT ninkovics sorafenibprimingmayaugmentsalvagechemotherapyinrelapsedandrefractoryflt3itdpositiveacutemyeloidleukemia AT bazargana sorafenibprimingmayaugmentsalvagechemotherapyinrelapsedandrefractoryflt3itdpositiveacutemyeloidleukemia AT filshier sorafenibprimingmayaugmentsalvagechemotherapyinrelapsedandrefractoryflt3itdpositiveacutemyeloidleukemia AT sutraveg sorafenibprimingmayaugmentsalvagechemotherapyinrelapsedandrefractoryflt3itdpositiveacutemyeloidleukemia AT hertzbergm sorafenibprimingmayaugmentsalvagechemotherapyinrelapsedandrefractoryflt3itdpositiveacutemyeloidleukemia AT scotta sorafenibprimingmayaugmentsalvagechemotherapyinrelapsedandrefractoryflt3itdpositiveacutemyeloidleukemia AT lanes sorafenibprimingmayaugmentsalvagechemotherapyinrelapsedandrefractoryflt3itdpositiveacutemyeloidleukemia AT yannakouck sorafenibprimingmayaugmentsalvagechemotherapyinrelapsedandrefractoryflt3itdpositiveacutemyeloidleukemia AT ritchied sorafenibprimingmayaugmentsalvagechemotherapyinrelapsedandrefractoryflt3itdpositiveacutemyeloidleukemia AT drozarioj sorafenibprimingmayaugmentsalvagechemotherapyinrelapsedandrefractoryflt3itdpositiveacutemyeloidleukemia AT blackj sorafenibprimingmayaugmentsalvagechemotherapyinrelapsedandrefractoryflt3itdpositiveacutemyeloidleukemia AT bavishik sorafenibprimingmayaugmentsalvagechemotherapyinrelapsedandrefractoryflt3itdpositiveacutemyeloidleukemia AT weia sorafenibprimingmayaugmentsalvagechemotherapyinrelapsedandrefractoryflt3itdpositiveacutemyeloidleukemia |